medicaid glp 1 weight loss As demand for weight-loss drugs rises, states grapple with coverage • Missouri Independent GLP-1s in the “Barbecue Belt

But because the FDA hasn't approved GLP-1s as an addiction treatment, insurance companies often won't pay for them when prescribed for addiction, keeping them out of reach for some patients who might benefit

Beyond the scale, it increases the risk of cardiovascular disease, stroke, type 2 diabetes, cancer, and even mental health disorders like anxiety and depression

The emergence of dual agonists like Tirzepatide shows how combining pathways can significantly enhance outcomes, raising the bar for both efficacy and patient results

Use intramuscular injections only when necessary, and dont inject in the same spot every time